🎉 Up to 70% Off Selected ItemsShop Sale
GLP-1 "Ozempic Target Zones" Precision Skincare Trio (MD PhD Protocol)
Targeting the rapid changes in facial volume and skin laxity often associated with GLP-1 use. This emergency kit provides intensive hydration and plumping agents to restore a youthful appearance.
Three zones expose you. Fix them.
Your main protocol handles overall volume. But three areas need specialized attention:
THE TELLTALE ZONES:
- Eyes: Hollowing begins week 8, visible by week 12
- Neck: Banding and crepiness accelerate 2x faster than face
- Nasolabial Folds: Deepen 2-3mm within 20 weeks
YOUR TARGETED ARSENAL:
- Advanced Retinol Eye Repair - Specifically formulated for 40% thinner periorbital skin
- Advanced Neck Lift Firming Complex - Addresses unique neck skin architecture
- Needle-Free Wrinkle Smoother - Instant fill plus long-term collagen stimulation
Apply ONLY to these three zones. Using elsewhere wastes product and reduces targeted efficacy.
$79.31
Original: $226.59
-65%GLP-1 "Ozempic Target Zones" Precision Skincare Trio (MD PhD Protocol)—
$226.59
$79.31Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Targeting the rapid changes in facial volume and skin laxity often associated with GLP-1 use. This emergency kit provides intensive hydration and plumping agents to restore a youthful appearance.
Three zones expose you. Fix them.
Your main protocol handles overall volume. But three areas need specialized attention:
THE TELLTALE ZONES:
- Eyes: Hollowing begins week 8, visible by week 12
- Neck: Banding and crepiness accelerate 2x faster than face
- Nasolabial Folds: Deepen 2-3mm within 20 weeks
YOUR TARGETED ARSENAL:
- Advanced Retinol Eye Repair - Specifically formulated for 40% thinner periorbital skin
- Advanced Neck Lift Firming Complex - Addresses unique neck skin architecture
- Needle-Free Wrinkle Smoother - Instant fill plus long-term collagen stimulation
Apply ONLY to these three zones. Using elsewhere wastes product and reduces targeted efficacy.
